Boryung Pharmaceutical → Changed company name to Boryung Co., Ltd…. Representatives Jeong-gyun Kim and Doo-hyeon Jang | yunhap news

Change of company name and appointment of new directors at regular general meeting

(Seoul = Yonhap News) Reporter Jandi Kim = Boryung Pharmaceutical[003850]announced on the 25th that it had approved the change of the company name from ‘Boryung Pharmaceutical Co., Ltd.’ to ‘Boryung Corporation’ at the regular general shareholders’ meeting on the 25th.

Boryung Pharmaceutical explained that the company changed its name to expand more growth and investment opportunities not only in the domestic pharmaceutical industry, but also in the global market and the healthcare industry in a changing environment.

The company plans to apply the new name to products, etc. from next month through a follow-up change procedure.

In addition, Boryung Pharmaceutical appointed Kim Jeong-gyun, CEO of Boryung Holdings, as an inside director at this shareholders’ meeting, and newly appointed CEO by the board of directors following the shareholders’ meeting.

As a result, the company will be operated under the system of CEO Kim Jeong-gyun and Jang Doo-hyun respectively.

Earlier this year, the company announced a full-fledged ‘third-generation management’ by appointing CEO Kim as the new president in January of this year.

CEO Kim is the grandson of Chairman Kim Seung-ho, the founder of Boryung Pharmaceutical Group, and the son of Chairman Kim Eun-sun of Boryeong Holdings. He joined Boryung Pharmaceutical as a director in January 2014 and worked through the strategic planning team, production management team, and HR team. From 2017, he served as an executive director and general manager of Boryung Holdings, a holding company. In December 2019, he was appointed as the CEO of Boryeong Holdings, and now also serves as the head of the business company, Boryeong Pharmaceutical.

At the same time, Boryung Pharmaceutical also voted on the appointment of Kim Seong-jin, head of the Boryung Pharmaceutical Global Investment Center, as an inside director, and AIA Life Advisor Cha Tae-jin as an outside director.

Boryeong Co., Ltd.

(Seoul = Yonhap News) Boryeong Co., Ltd. 2022.03.25. [보령 제공. 재판매 및 DB 금지]

jandi@yna.co.kr

Leave a Replay